The Effects of Repetitive Transcranial Magnetic Stimulation at Dorsolateral Prefrontal Cortex in the Treatment of Migraine Comorbid with Depression: A Retrospective Open Study
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: The literature on managing migraine non-responsive to pharmacological approaches and that co-occurring with depression is scanty. The comorbid condition predicts a poorer prognosis for migraine as well as depression. The present report assesses efficacy and tolerability of high frequency repetitive transcranial magnetic stimulation (rTMS) over left dorsolateral prefrontal cortex as a treatment modality for migraine with comorbid depression. Methods: The current retrospective chart review assesses effectiveness of high frequency rTMS over left dorsolateral prefrontal cortex as a treatment modality to manage migraine occurring comorbid with depression in 14 subjects. Results: The mean scores on Migraine Disability Assessment Test (MIDAS) and depression rating scale reduced significantly from 21.14±3.01 and 20.71±3.95 at baseline to 13.93±6.09 and 14.21±5.52 respectively, after rTMS. There was significant improvement in migraine frequency, severity and functional disability assessed using MIDAS scores (p <0.05) following high frequency rTMS compared to baseline. Conclusion: There is a role of applying rTMS as a potential therapeutic modality in the integrated management of a distinct subgroup of migraine patients with comorbid depression.
Abstract
Objective: The literature on managing migraine non-responsive to pharmacological approaches and that co-occurring with depression is scanty. The comorbid condition predicts a poorer prognosis for migraine as well as depression. The present report assesses efficacy and tolerability of high frequency repetitive transcranial magnetic stimulation (rTMS) over left dorsolateral prefrontal cortex as a treatment modality for migraine with comorbid depression. Methods: The current retrospective chart review assesses effectiveness of high frequency rTMS over left dorsolateral prefrontal cortex as a treatment modality to manage migraine occurring comorbid with depression in 14 subjects. Results: The mean scores on Migraine Disability Assessment Test (MIDAS) and depression rating scale reduced significantly from 21.14±3.01 and 20.71±3.95 at baseline to 13.93±6.09 and 14.21±5.52 respectively, after rTMS. There was significant improvement in migraine frequency, severity and functional disability assessed using MIDAS scores (p <0.05) following high frequency rTMS compared to baseline. Conclusion: There is a role of applying rTMS as a potential therapeutic modality in the integrated management of a distinct subgroup of migraine patients with comorbid depression.
참고문헌 (24)
- Global Burden of Disease Study 2013 Collaborators, "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013", Lancet, 386, pp.743~800 (2015)[DOI]
- Hamelsky SW, "Psychiatric comorbidity of migraine", Headache, 46, pp.1327~1333 (2006)[DOI]
- Lampl C, "Headache, depression and anxiety: associations in the Eurolight project", J Headache Pain, 17, pp.59~ (2016)[DOI]
- Lanteri-Minet M, "Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management", Pain, 118, pp.319~326 (2005)[DOI]
- Breslau N, "Comorbidity of migraine and depression: investigating potential etiology and prognosis", Neurology, 60, pp.1308~1312 (2003)[DOI]
- Baskin SM, "Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications", Neurol Sci, 30(Suppl 1), pp.S61~S65 (2009)[DOI]
- André Aleman, "Use of Repetitive Transcranial Magnetic Stimulation for Treatment in Psychiatry", Clinical Psychopharmacology and Neuroscience, 11(2), pp.53~59 (2013), 대한정신약물학회
- Li CT, "Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism", J Affect Disord, 127, pp.219~229 (2010)[DOI]
- Mongini F, "Frontal lobe dysfunction in patients with chronic migraine: a clinical-neuropsychological study", Psychiatry Res, 133, pp.101~106 (2005)[DOI]
- Brighina F, "Abnormal facilitatory mechanisms in motor cortex of migraine with aura", Eur J Pain, 15, pp.928~935 (2011)[DOI]
- Headache Classification Subcommittee of the International Headache Society, "The International Classification of Headache Disorders: 2nd edition", Cephalalgia, 24(Suppl 1), pp.9~160 (2004)[DOI]
- Hamilton M, "A rating scale for depression", J Neurol Neurosurg Psychiatry, 23, pp.56~62 (1960)[DOI]
- Rossi S, "Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research", Clin Neurophysiol, 120, pp.2008~2039 (2009)[DOI]
- Pascual-Leone A, "Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression", Lancet, 348, pp.233~237 (1996)[DOI]
- Stewart WF, "An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score", Neurology, 53, pp.988~994 (1999)[DOI]
- Brighina F, "rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study", J Neurol Sci, 227, pp.67~71 (2004)[DOI]
- Lorenz J, "Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation", Brain, 126, pp.1079~1091 (2003)[DOI]
- Rome JD, "Limbically augmented pain syndromes: kindling andcorticolimbic sensitisation", Cephalalgia, 21, pp.241~245 (2001)[DOI]
- Misra UK, "Is <TEX>${\beta}$<", TEX> endorphin related to migraine headache and its relief?, 2013, pp.33, 316~322
- Conforto AB, "Randomized, proof-of-principle clinical trial of active transcranial magnetic stimulation in chronic migraine", Cephalalgia, 34, pp.464~472 (2014)[DOI]
- Gudmundsson LS, "Migraine, depression, and brain volume: the AGES-Reykjavik Study", Neurology, 80, pp.2138~2144 (2013)[DOI]
- Maizels M, "A review of screening tools for psychiatric comorbidity in headache patients", Headache, 46(Suppl 3), pp.S98~S109 (2006)[DOI]
- Perera T, "The Clinical TMS Society consensus review and treatment recommendations for TMS therapy for major depressive disorder", Brain Stimul, 9, pp.336~346 (2016)[DOI]
- Macedo A, "Placebo response in the prophylaxis of migraine: a meta-analysis", Eur J Pain, 12, pp.68~75 (2008)[DOI]
